Teva Branded Pharmaceutical Products R&d Llc

This study tests an experimental oral drug, TEV-56286, in 350 adults with multiple system atrophy (MSA), a rare and progressive brain disorder. Participants will receive either the drug or a placebo for 48 weeks to see if it slows disease worsening and is safe. The goal is to fin…

This early-phase trial tests a new drug called TEV-56278, alone or with pembrolizumab, in people with advanced solid tumors that have stopped responding to standard treatments. The main goals are to check safety, find the best dose, and see if the drug shrinks tumors. About 240 p…

This study tests a new inhaler that combines two common asthma medicines (fluticasone and albuterol) to see if it works better than each medicine alone or a placebo. About 724 people aged 12 and older with asthma will use the inhaler four times daily for four weeks. The goal is t…